| CME ARTICLE |
|
| Year : 2014 | Volume
: 7
| Issue : 2 | Page : 75-85 |
|
|
Management of infantile hemangiomas: Current trends
Gomathy Sethuraman, Vamsi K Yenamandra, Vishal Gupta
Department of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi, India
Correspondence Address:
Dr. Gomathy Sethuraman
Department of Dermatology, All India Institute of Medical sciences, New Delhi - 110 029
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0974-2077.138324
|
|
|
Infantile hemangiomas (IH) are common vascular tumours. IH have a characteristic natural course. They proliferate rapidly during the early infantile period followed by a period of gradual regression over several years. Most of the uncomplicated IH undergo spontaneous involution, with a small proportion of cases requiring intervention. These are children with IH in life-threatening locations, local complications like haemorrhage, ulceration and necrosis and functional or cosmetic disfigurements. Systemic corticosteroids have been the first line of treatment for many years. Recently, non-selective beta-blockers, such as oral propranalol and topical timolol, have emerged as promising and safer therapies. Other treatment options include interferon α and vincristine which are reserved for life-threatening haemangiomas that are unresponsive to conventional therapy. This review mainly focuses on the current trends and evidence-based approach in the management of IH. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
